- Home
- XBP vs BOLD Comparison
XBP vs BOLD Comparison
Compare XBP & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- BOLD
- Stock Information
- Founded
- XBP N/A
- BOLD 2018
- Country
- XBP United Kingdom
- BOLD United States
- Employees
- XBP N/A
- BOLD N/A
- Industry
- XBP Business Services
- BOLD
- Sector
- XBP Consumer Discretionary
- BOLD
- Exchange
- XBP Nasdaq
- BOLD Nasdaq
- Market Cap
- XBP 32.2M
- BOLD 24.4M
- IPO Year
- XBP N/A
- BOLD 2024
- Fundamental
- Price
- XBP $0.90
- BOLD $1.14
- Analyst Decision
- XBP
- BOLD Buy
- Analyst Count
- XBP 0
- BOLD 3
- Target Price
- XBP N/A
- BOLD $4.00
- AVG Volume (30 Days)
- XBP 83.4K
- BOLD 278.2K
- Earning Date
- XBP 08-11-2025
- BOLD 08-11-2025
- Dividend Yield
- XBP N/A
- BOLD N/A
- EPS Growth
- XBP N/A
- BOLD N/A
- EPS
- XBP N/A
- BOLD N/A
- Revenue
- XBP $142,332,000.00
- BOLD N/A
- Revenue This Year
- XBP N/A
- BOLD N/A
- Revenue Next Year
- XBP N/A
- BOLD N/A
- P/E Ratio
- XBP N/A
- BOLD N/A
- Revenue Growth
- XBP N/A
- BOLD N/A
- 52 Week Low
- XBP $0.79
- BOLD $1.00
- 52 Week High
- XBP $1.89
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- XBP 41.32
- BOLD N/A
- Support Level
- XBP $0.89
- BOLD N/A
- Resistance Level
- XBP $0.98
- BOLD N/A
- Average True Range (ATR)
- XBP 0.07
- BOLD 0.00
- MACD
- XBP 0.01
- BOLD 0.00
- Stochastic Oscillator
- XBP 29.80
- BOLD 0.00
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.